Related Experiment Video

Updated: May 3, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

4.5K

Safety of high-dose micafungin for patients with hematological diseases

Sho Yamazaki1, Fumihiko Nakamura, Akihide Yoshimi

  • 1Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo , Tokyo , Japan.

Leukemia & Lymphoma
|January 28, 2014
PubMed

Insights

Micafungin at 300 mg daily is safe for patients with hematological diseases. Adverse events were similar to the 150 mg dose, with no increase in serious issues.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Infectious Diseases

Background:

  • Micafungin is an echinocandin antifungal agent.
  • Its safety at doses exceeding 150 mg daily requires further elucidation, particularly in specific patient populations.

Purpose of the Study:

  • To evaluate the safety and tolerability of high-dose micafungin (300 mg daily) compared to standard-dose (150 mg daily).
  • To assess adverse events in adult patients with hematological diseases receiving micafungin therapy.

Main Methods:

  • Retrospective, observational, exploratory cohort study.
  • Comparison of 26 patients receiving micafungin 300 mg/day with 58 patients receiving 150 mg/day for ≥ 7 days.
  • Analysis of adverse events, including hepatotoxicity, hypertension, and diarrhea.

Main Results:

  • Adverse events occurred in 72% of the standard-dose group and 73% of the high-dose group (p = 1.00).
  • Hepatobiliary adverse events were observed in 48% and 58% of patients, respectively (p = 0.48).
  • Serious adverse events and treatment discontinuation were infrequent in both groups.

Conclusions:

  • Micafungin at 300 mg daily appears safe and well-tolerated in adult patients with hematological diseases.
  • The safety profile at higher doses is comparable to the standard dose.
Keywords:
Micafunginadverse eventshepatotoxicityhigh dosesafety

More Related Videos

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

12.1K
Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

11.4K

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
119
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
386
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
423
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
782